| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |